Fortress Biotech Inc (FBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 136,858 | 134,945 | 149,407 | 116,444 | 65,508 |
| Marketable Securities | N/A | 19,929 | 5,000 | 5,044 | 17,604 |
| Receivables | 14,404 | 6,380 | 4,954 | 10,151 | 7,593 |
| Inventories | 857 | 941 | 732 | 629 | 678 |
| Other current assets | 0 | 0 | 0 | 0 | 13,089 |
| TOTAL | $156,252 | $166,312 | $163,511 | $136,549 | $111,207 |
| Non-Current Assets | |||||
| PPE Net | 12,433 | 12,152 | 12,023 | 11,833 | 12,019 |
| Investments And Advances | 11,148 | 11,193 | 11,193 | 11,056 | 0 |
| Intangibles | 7,377 | 7,731 | 971 | 1,183 | 1,417 |
| Other Non-Current Assets | 39,212 | 24,200 | 39,566 | 39,917 | 16,350 |
| TOTAL | $70,170 | $55,276 | $63,753 | $63,989 | $29,786 |
| Total Assets | $226,422 | $221,588 | $227,264 | $200,538 | $140,993 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 36,585 | 29,640 | 25,376 | 38,199 | 35,396 |
| Accrued Expenses | N/A | N/A | N/A | N/A | 149 |
| Other current liabilities | 27 | N/A | N/A | N/A | 991 |
| TOTAL | $45,616 | $46,853 | $36,398 | $48,957 | $55,614 |
| Non-Current Liabilities | |||||
| Long Term Debt | 82,426 | 68,542 | 74,307 | 73,607 | 60,425 |
| Other Non-Current Liabilities | 43,311 | 43,401 | 41,121 | 44,912 | 19,746 |
| TOTAL | $108,274 | $99,735 | $101,046 | $100,872 | $65,636 |
| Total Liabilities | $153,890 | $146,588 | $137,444 | $149,829 | $121,250 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 5,233 | 4,721 | 4,605 | 4,351 | 4,089 |
| Common Shares | 574 | 570 | 558 | 828 | 717 |
| Retained earnings | -436,234 | -420,742 | -407,980 | -394,882 | -396,274 |
| Other shareholders' equity | 46,317 | 49,205 | 57,946 | 29,892 | 17,891 |
| TOTAL | $72,532 | $75,000 | $89,820 | $50,709 | $19,743 |
| Total Liabilities And Equity | $226,422 | $221,588 | $227,264 | $200,538 | $140,993 |